3-acetamidobenzamide has been researched along with dacarbazine in 1 studies
| Studies (3-acetamidobenzamide) | Trials (3-acetamidobenzamide) | Recent Studies (post-2010) (3-acetamidobenzamide) | Studies (dacarbazine) | Trials (dacarbazine) | Recent Studies (post-2010) (dacarbazine) |
|---|---|---|---|---|---|
| 8 | 0 | 0 | 7,556 | 1,463 | 3,429 |
| Protein | Taxonomy | 3-acetamidobenzamide (IC50) | dacarbazine (IC50) |
|---|---|---|---|
| Matrix metalloproteinase-9 | Homo sapiens (human) | 0.556 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harris, AL; Lunn, JM | 1 |
1 other study(ies) available for 3-acetamidobenzamide and dacarbazine
| Article | Year |
|---|---|
Cytotoxicity of 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (MTIC) on Mer+, Mer+Rem- and Mer- cell lines: differential potentiation by 3-acetamidobenzamide.
Topics: Alkylating Agents; Benzamides; Cell Survival; Dacarbazine; DNA Damage; Dose-Response Relationship, Drug; Drug Synergism; Humans; Mitosis; NAD; Nucleotidyltransferases; Tumor Cells, Cultured | 1988 |